Naproxeno Infectopharm (Naproxen)

Naproxen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. Prostaglandins amplify inflammation, pain, and fever. By lowering prostaglandin levels, naproxen diminishes the inflammatory response and reduces the perception of pain.

The specific dosage of Naproxeno Infectopharm is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, renal and hepatic function, and other individual factors. Healthcare professionals set the appropriate dose and dosing interval for each patient.

Naproxen should be used only if clearly needed during pregnancy, especially in the third trimester, because it may affect fetal cardiovascular function. It is excreted in breast milk, so breastfeeding mothers should discuss potential risks with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naproxen has a longer half‑life than ibuprofen, allowing less frequent dosing for chronic conditions. Both share similar mechanisms of COX inhibition, but naproxen may have a slightly lower risk of cardiovascular events compared with some selective COX‑2 inhibitors, while still carrying typical NSAID gastrointestinal risks.

Store Naproxeno Infectopharm at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight to maintain product stability throughout its shelf life.

The product is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe kidney injury, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, chest pain, sudden kidney problems, or severe skin rash.

Individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, recent coronary artery bypass surgery, or significant renal or hepatic impairment should avoid using Naproxeno Infectopharm unless directed by a qualified healthcare professional.